Tag: Tocilizumab

Age, time, and treatment determine relapse risk in MOGAD

Presented By
Dr Vivien Häußler, University Medical Center Hamburg, Germany
Conference
ECTRIMS 2024
Type
Peer-reviewed article

18 November 2024 11:56

Mitochondrial DNA levels predict COVID-19 severity

Presented By
Dr Marlene Cano, Washington University in Saint Louis, MO, USA
Conference
ATS 2023
Type
News article

12 June 2023 15:47

Immunomodulatory therapies for severe COVID-19: literature update

Presented By
Dr Alessia Alunno, University of Perugia, Italy
Trial
RECOVERY, REMAP-CAP
Conference
EULAR 2021
Type
Peer-reviewed article

2 August 2021 21:50

TOVERA: Ultrasound is a promising biomarker of early treatment response

Presented By
Dr Maria Stoenoiu, Cliniques Universitaires Saint-Luc, Belgium
Trial
Phase 3, TOVERA
Conference
EULAR 2021
Type
Peer-reviewed article

2 August 2021 21:00

New agent with great potential for the treatment of giant cell arteritis in the pipeline

Presented By
Dr Maria Cinta Cid, Hospital Clínic of Barcelona, Spain
Conference
ACR 2020
Type
Peer-reviewed article

18 January 2021 11:02

Rheumatoid arthritis and interstitial lung disease: a deadly combination

Presented By
Prof. Joan Bathon, Columbia University, USA
Conference
ACR 2020
Type
Peer-reviewed article

18 January 2021 10:59

COVID-19 treatments and the importance of randomised trials

Presented By
Prof. Martin Landray, University of Oxford, UK
Trial
RECOVERY
Conference
ESC 2020
Type
Peer-reviewed article

5 November 2020 11:49

Few serious infections in offspring with exposure to non-TNFi biologics or tofacitinib

Presented By
Dr Evelyne Vinet, McGill University, Montreal, Canada
Conference
ACR 2019
Type
Peer-reviewed article

4 February 2020 23:12

Tocilizumab outperforms rituximab in RA patients with low level of synovial B cell infiltration

Presented By
Prof. Costantino Pitzalis, Barts and The London School of Medicine and Dentistry, UK
Conference
ACR 2019
Type
Peer-reviewed article

4 February 2020 20:10

Prolonged remission after stop of tocilizumab for patients with giant cell arteritis

Presented By
Prof. John H. Stone, Harvard Medical School, Boston, USA
Trial
Phase 3, GiACTA
Conference
ACR 2019
Type
Peer-reviewed article

4 February 2020 10:19

Interstitial lung disease in rheumatic diseases and systemic sclerosis

Presented By
Dr Jan Grutters, University Medical Center Utrecht, the Netherlands
Trial
SENSCIS, INPULSIS, SLS-2
Conference
EULAR 2019
Type
Peer-reviewed article

4 September 2019 23:50

Tapering of prednisone in RA patients who achieved low disease activity or remission with tocilizumab

Presented By
Prof. Gerd Burmester, Free University and Humboldt University of Berlin, Germany
Conference
EULAR 2019
Type
Peer-reviewed article

4 September 2019 16:56

Support for tocilizumab use in giant cell arteritis

Presented By
Dr John Stone, Massachusetts General Hospital, Boston, USA
Trial
GiACTA
Conference
EULAR 2019
Type
Peer-reviewed article

4 September 2019 10:53

Novel systemic sclerosis drugs: an overview of what might be to come

Trial
Phase 3, RESOLVE-1
Conference
EULAR 2018
Type
Peer-reviewed article

24 August 2018 23:46

Biologic drug levels and infection risk, and clinical effectiveness of sarilumab

Trial
TARGET
Conference
EULAR 2018
Type
Peer-reviewed article

24 August 2018 19:30
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com